2009年长江流域6城市口服抗糖尿病药应用分析  

Utilization of Oral Antidiabetic Drugs in Hospitals of 6 Cities along Yangtze River Valley during 2009

作　　者：张吉[1] 邹颖[1] 冯琳[1] 

机构地区：[1]南京医科大学第一附属医院药剂科,南京210029

出　　处：《中国医院用药评价与分析》2011年第7期613-616,共4页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:了解2009年长江流域6城市口服抗糖尿病药的应用现状及趋势。方法:应用金额排序法和用药频度排序法,对193家入网医院2009年临床使用的口服抗糖尿病药进行统计和分析。结果:2009年长江流域6城市口服抗糖尿病药总金额为4.9亿元,其中上海地区由于人口因素用药总金额最高。无论是总金额还是各城市金额排序,居第1位的药品均为阿卡波糖,占总额比例达36%左右。总DDDs排序居第1位的药品为二甲双胍,各城市DDDs排序居第1位的药品主要是二甲双胍、阿卡波糖、格列美脲。结论:2009年长江流域口服抗糖尿病药在临床使用基本合理,市场需求潜力大,高效、安全、依从性好的药物受到临床青睐。OBJECTIVE： To understand the status quo and tendency of utilization of oral antidiabetic drugs in hospitals of 6 cities along Yangtze River valley.METHODS： The use of oral antidiabetic drugs in 193 hospitals of 6 cities along Yangtze River valley during 2009 was analyzed statistically using the methods of consumption sum ordering and DDDs ordering.RESULTS： The consumption sum of oral antidiabetic drugs in the hospitals of 6 cities along Yangtze River valley in 2009 stood at 490 millions Yuan,with that in Shanghai area leading the list on account of population factor.Acarbose took the lead in both consumption sum and consumption sum order among 6 cities,which accounted for about 36% of the total.Metformin took the lead in terms of DDDs.The drugs leading the list in terms of DDDs in the 6 cities were mainly Metformin,Acarbose and Glimepiride.CONCLUSION： The use of oral antidiabetic drugs in the hospitals along Yangtze River valley during 2009 was rational on the whole.The antidiabetic drugs with great market demand,higher efficiency,good safety and good compliance are favored by clinic.

关 键 词：口服抗糖尿病药 药物利用 限定日剂量 

分 类 号：R977.15[医药卫生—药品]